03/04/2015 - 6:28pm

While the big four analgesic manufacturers — Bayer, Pfizer, McNeil and Novartis — command the lion’s share of retail ad support behind their mega analgesic brands, Prestige Brands and BedRock Brands are making headway promoting their niche pain relieving products.

03/04/2015 - 6:28pm

Almost half of all circular ads in support of a digestive remedy promote an antacid tablet. 

03/04/2015 - 6:28pm

According to ECRM’s analysis of circular retail promotions for allergy, Chattem emerged as the leading advertiser of allergy remedies.

03/04/2015 - 6:28pm

Chattem’s launch of the first nasal corticosteroid onto OTC shelves represented the most significant success story in the cough-cold-allergy space in the past year. 

03/04/2015 - 6:28pm

Immunity boosters and hand sanitizer are on most shopping lists as consumers prepare their families for the inevitable sniffles, sneezes and coughs associated with the cold and flu season.

03/04/2015 - 6:28pm

In preparation for the Consumer Healthcare Products Association’s 2015 Annual Executive Conference being held in Bonita Springs, Fla., this month, Drug Store News sat down with both Scott Melville, CHPA president and CEO, and Patrick Lockwood-Taylor, CHPA chair and VP personal health care, North America, for Procter & Gamble.

03/04/2015 - 6:28pm

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.

03/04/2015 - 6:27pm

In a meeting with nearly two dozen leaders representing consumers, insurers, providers and business leaders, Health and Human Services Secretary Sylvia Burwell on Jan. 26 announced measurable goals and a timeline to move the Medicare program, and the healthcare system at large, toward paying providers based on the quality of care they give patients.

03/04/2015 - 6:27pm

Miraculins in January announced that it will be commencing a pilot program with Lovell Drugs and Pear Healthcare Solutions that will see the placement of the first stand-alone Scout DS diabetes screening kiosks in Lovell’s retail pharmacy locations in Ontario beginning in February.